Esperion Therapeutics
ESPR
#7593
Rank
A$0.47 B
Marketcap
$2.39
Share price
-6.83%
Change (1 day)
-44.23%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of December 2024 : -A$0.62 Billion

According to Esperion Therapeutics's latest financial reports the company has -A$0.62 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$-A$0.63 Billion-6.42%
2023-12-31$-A$0.67 Billion40.36%
2022-12-31$-A$0.48 Billion75.15%
2021-12-31$-A$0.28 Billion117.28%
2020-12-31$-A$0.13 Billion-538.77%
2019-12-31$A$28.49 M-74.63%
2018-12-31$A$0.11 B-64.17%
2017-12-31$A$0.31 B-1.17%
2016-12-31$A$0.31 B-19.57%
2015-12-31$A$0.39 B141.63%
2014-12-31$A$0.16 B96.46%
2013-12-31$A$83.06 M-596.38%
2012-12-31$-A$16.74 Million183.28%
2011-12-31$-A$5.91 Million
2002-12-31$A$68.76 M-47.22%
2001-12-31$A$0.13 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.41 B-167.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.00 B-1,555.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$140.87 B-22,866.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$46.72 B-7,651.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.30 B-149.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.23 B-137.55%๐Ÿ‡บ๐Ÿ‡ธ USA